Life sciences investor KdT Ventures raises $100M fund to back new startups

Kyle LaHucik

Senior Reporter

Life sciences VC shop KdT Ventures disclosed its $100 million fourth fund on Wednesday morning, just over two years after announcing an $80 million fund …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Life sciences investor KdT Ventures raises $100M fund to back new startups

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Facing a critical week, Pfizer confronts an unsparing foe in Starboard

FDA places hold on Novavax's Covid-flu and standalone influenza vaccines

FDA leaders kick off rare disease hub to increase cross-center collaboration

First clinical test of RNA editing restores missing protein in genetic disease, Wave says

Q&A: Sanofi’s R&D head reflects on his first year, a post-Dupixent future, and finding an identity

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

Life sci­ences in­vestor KdT Ven­tures rais­es $100M fund to back new star­tups

Senior Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Life sciences investor KdT Ventures raises $100M fund to back new startups